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Background
Generation and dissemination of information has been a
crucial area for actions in the field of rare diseases. In this
context, rare disease patients and their experience are
recognised as a unique source of information that could
trigger important developments for all stakeholders.
The European Network of Rare Disease Help Lines
(ENRDHLs) is an initiative led by EURORDIS. ENRDHLs
was created within the EU-funded Rapsody with the main
aim of improving the quality of services provided by
European help lines for rare diseases. In order to fulfill this
objective, various rare diseases information services from
across Europe came together to share expertise and
propose ways in which the network could support other
services in Europe.
Materials and methods
The Caller Profile Analysis is one of the mandatory
commitments for the ENRDHLs members. It is a cross-
sectional survey that describes the rare disease helpline
services, provided by the participating partners for a
specific month. The 2013 survey covered all enquiries
received from 1 to 30 October 2013.
Results
12 rare disease helplines from 8 countries (France, Italy,
Spain, Switzerland, Portugal, Romania, Bulgaria and
Croatia) took part in the Caller Profile Analysis 2013,
giving information on 1 672 enquiries. The typical user
would be a female patient, aged 30-50 years old. The
overall volume of enquiries served has been relatively
stable for the period of 2011-2013, with an increased
number of enquiries on centres of expertise and a
decreased number of enquires on information on specific
rare diseases. These combined outcomes demonstrate the
still unmet needs of rare disease patients for information.
Patients hope that this gap could be efficiently filled by
the ongoing designation of centres of expertise through-
out Europe.
Conclusions
Despite the acknowledged progress in rare disease field at
both EU and national level and the increased role of
social media, traditional helpline information services do
have their importance for rare diseases stakeholders and
especially for patients. They have a proven record for
effectively empowering patients, giving them the capacity
to communicate, to collaborate and to advocate for rare
disease policy and actions. And empowered patients are
the common denominator that sticks together all rare
disease stakeholders and make changes occur.
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